Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
暂无分享,去创建一个
Martin Schumacher | Peggy Sekula | Maja Mockenhaupt | Alain Hovnanian | Rémi Kazma | L. Naldi | E. Génin | M. Schumacher | M. Mockenhaupt | J. Roujeau | A. Hovnanian | P. Sekula | Luigi Naldi | Emmanuelle Génin | Jean-Claude Roujeau | R. Kazma | Yvonne Liss | Y. Liss | Yvonne Liss
[1] R. Abe. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. , 2008, Journal of dermatological science.
[2] L. Naldi,et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. , 2008, Journal of the American Academy of Dermatology.
[3] Weihua Guan,et al. Genotype‐based matching to correct for population stratification in large‐scale case‐control genetic association studies , 2009, Genetic epidemiology.
[4] David B. Goldstein,et al. Population genetic structure of variable drug response , 2001, Nature Genetics.
[5] M Pirmohamed,et al. Genetic susceptibility to adverse drug reactions. , 2001, Trends in pharmacological sciences.
[6] R. Pellicano,et al. Familial occurrence of fixed drug eruptions. , 1992, Acta dermato-venereologica.
[7] Jonathan Scott Friedlaender,et al. A Human Genome Diversity Cell Line Panel , 2002, Science.
[8] L. Hughes-Davies,et al. Severe adverse cutaneous reactions to drugs. , 1995, The New England journal of medicine.
[9] Yuan-Tsong Chen,et al. A marker for Stevens–Johnson syndrome , 2004 .
[10] Peter Donnelly,et al. A statistical method for predicting classical HLA alleles from SNP data. , 2008, American journal of human genetics.
[11] Fredrik Nyberg,et al. Optimizing the Power of Genome-Wide Association Studies by Using Publicly Available Reference Samples to Expand the Control Group , 2010, Genetic epidemiology.
[12] John W. Miller. Of Race, Ethnicity, and Rash: The Genetics of Antiepileptic Drug-Induced Skin Reactions , 2008, Epilepsy currents.
[13] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[14] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[15] Ann B. Lee,et al. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. , 2008, American journal of human genetics.
[16] M. Mockenhaupt,et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. , 1996, Journal of clinical epidemiology.
[17] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[18] J. Roujeau,et al. Genetic susceptibility to toxic epidermal necrolysis. , 1987, Archives of dermatology.
[19] Yuan-Tsong Chen,et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Schumacher,et al. A marker for Stevens-Johnson syndrome …: ethnicity matters , 2006, The Pharmacogenomics Journal.
[21] D. Reich,et al. Population Structure and Eigenanalysis , 2006, PLoS genetics.
[22] Ryan D. Hernandez,et al. Assessing the Evolutionary Impact of Amino Acid Mutations in the Human Genome , 2008, PLoS genetics.
[23] Munir Pirmohamed,et al. Genetic factors in the predisposition to drug-induced hypersensitivity reactions , 2006, The AAPS Journal.
[24] Pardis C Sabeti,et al. Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. , 2006, American journal of human genetics.
[25] Shamil R Sunyaev,et al. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. , 2007, American journal of human genetics.
[26] Marie-Claude Babron,et al. American Journal of Epidemiology Practice of Epidemiology Genetic Association and Gene-environment Interaction: a New Method for Overcoming the Lack of Exposure Information in Controls , 2022 .
[27] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[28] W. Bodmer,et al. Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.
[29] S. Tiamkao,et al. Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population , 2009, Pharmacogenetics and genomics.
[30] Francis S Collins,et al. A HapMap harvest of insights into the genetics of common disease. , 2008, The Journal of clinical investigation.
[31] Korbinian Strimmer,et al. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates , 2008, Bioinform..
[32] M. Nelson,et al. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients , 2009, Pharmacogenetics and genomics.
[33] Mark I McCarthy,et al. Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery , 2009, Genome Medicine.
[34] E. Lander,et al. On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.
[35] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[36] S. Heath,et al. Investigation of the fine structure of European populations with applications to disease association studies , 2008, European Journal of Human Genetics.
[37] Pardis C Sabeti,et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.
[38] J. Roujeau,et al. HLA phenotypes and bullous cutaneous reactions to drugs. , 2008, Tissue antigens.
[39] A. Novelletto,et al. Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations , 2008, PloS one.
[40] W. Bodmer,et al. Rare Variant Hypothesis for Multifactorial Inheritance: Susceptibility to Colorectal Adenomas as a Model , 2005, Cell cycle.
[41] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[42] Clive E. Bowman,et al. Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2007, Pharmacogenomics.
[43] B. Tank,et al. Cutaneous drug reactions. , 1996, Indian journal of dermatology, venereology and leprology.
[44] R. Melsom. Familial hypersensitivity to allopurinol with subsequent desensitization. , 1999, Rheumatology.
[45] L. Naldi,et al. A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs , 2008, Pharmacogenetics and genomics.
[46] L. Naldi,et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. , 2008, The Journal of investigative dermatology.
[47] M. Spitz,et al. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. , 2008, American journal of human genetics.
[48] L. Naldi,et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. , 2002, Archives of dermatology.